Mary Sheon, Kulkarni Mahesh J, Mehendale Savita S, Joshi Sadhana R, Giri Ashok P
Division of Biochemical Sciences, CSIR-National Chemical Laboratory, Pune, Maharashtra 411008 India.
Department of Gynecology, Bharati Vidyapeeth Medical College, Pune, Maharashtra 411043 India.
Clin Proteomics. 2017 Mar 21;14:8. doi: 10.1186/s12014-017-9144-2. eCollection 2017.
Tubulointerstitial nephritis antigen-like 1 protein (TINAGL1), is a matricellular protein, known to play role in cell adhesion and cell receptor interaction. Research related to TINAGL1 is limited to cell culture and animal models. Demonstration of TINAGL1 as a positive regulator of angiogenesis and its expression in the decidua of postimplantation mouse uterus, prompted us to validate its expression in human placenta during impaired angiogenesis in pre-eclamptic condition.
Placental tissue from normotensive (n = 25) and pre-eclamptic (n = 25) pregnancies were used to study the differentially expressed proteins by two-dimensional gel electrophoresis and TINAGL1 protein was validated with Western blotting.
A total of 55 protein spots were differentially expressed (fold change >1.5, p < 0.05), of which 27 were upregulated and 28 were downregulated in the pre-eclamptic placenta. TINAGL1 was found to be downregulated in pre-eclamptic compared to normotensive pregnant women.
This is the first study reporting TINAGL1 to be present in human placenta and differentially expressed in pre-eclamptic condition. The functional role of TINAGL1 in association to human pregnancy needs to be explored further.
肾小管间质性肾炎抗原样1蛋白(TINAGL1)是一种基质细胞蛋白,已知其在细胞黏附和细胞受体相互作用中发挥作用。与TINAGL1相关的研究仅限于细胞培养和动物模型。TINAGL1作为血管生成的正向调节因子及其在植入后小鼠子宫蜕膜中的表达,促使我们验证其在子痫前期血管生成受损时人胎盘中的表达。
采用来自血压正常(n = 25)和子痫前期(n = 25)孕妇的胎盘组织,通过二维凝胶电泳研究差异表达蛋白,并用蛋白质印迹法验证TINAGL1蛋白。
共55个蛋白点差异表达(变化倍数>1.5,p < 0.05),其中子痫前期胎盘中27个上调,28个下调。与血压正常的孕妇相比,子痫前期孕妇的TINAGL1表达下调。
这是第一项报道TINAGL1存在于人胎盘中且在子痫前期状态下差异表达的研究。TINAGL1与人类妊娠相关的功能作用有待进一步探索。